Flu vaccine

Universal flu vaccine means big bucks for biotech firms

Illustration: Rebecca Zisser/Axios

Osivax, a French developer of a universal flu vaccine, raised €8 million in Series A funding led by Noshaq.

Why it matters: Developing a universal flu vaccine is fast becoming biotech's holy grail.

Vaccine safety concern has regional differences: Wellcome survey

Photo of child in Bangladesh wincing as she receives her MMR shot
A Rohingya refugee gets an MMR vaccine at camp in Bangladesh in November 2017. Photo: Munir Uz Zaman/AFP/Getty Images

While 79% of people worldwide "somewhat" or "strongly agree" that vaccines are safe, certain parts of the world have a concerning level of disbelief, particularly in parts of Europe, according to a large Gallup survey for charitable foundation Wellcome Trust released on Wednesday.

Why it matters: The global health community is trying understand and combat pockets of anti-vaccination or vaccine hesitancy, which have recently led to some devastating outbreaks, such as from the highly contagious but preventable measles, even though vaccine injuries are rare.